Relief Therapeutics Holding announces half year results
The European cannabis company also announces a new Chief Medical Officer.
Relief Therapeutics Holding AG (OTCQB: RLFTF): 1H GAAP EPS of CHF 0.004. EBITDA loss of CHF 1.25 million Cash and cash equivalents in the amount of 1.67 million CHF Dr. Gilles Della Corte named Chief Medical Officer. "The company is fully funded to successfully complete the two ongoing US COVID-19 studies and is now preparing for European studies with RLF-100," commented Raghuram (Ram) Selvaraju, Chairman of the Board of Relief.